Literature DB >> 7517041

Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.

Y Zevering1, C Khamboonruang, K Rungruengthanakit, L Tungviboonchai, J Ruengpipattanapan, I Bathurst, P Barr, M F Good.   

Abstract

The longevity of specific human memory T-cell responses is largely unknown. However, a knowledge of the duration of memory is important for understanding immunity to an organism and for planning vaccine intervention. To address this, we have examined T-cell memory to malaria by determining T-cell responses by subjects recently exposed to peptides spanning the circumsporozoite (CS) proteins of two species of malaria-causing organisms, Plasmodium falciparum and Plasmodium vivax. Responses to vivax CS peptides by exposed Thai subjects were more frequent than responses by nonexposed individuals, permitting identification of determinants seen by vivax-induced responses. At the population level, there appears to be life-long memory, as the time since individuals were exposed did not diminish responsiveness to these determinants. In contrast, falciparum-exposed subjects were largely indistinguishable from nonexposed controls in responsiveness to falciparum CS determinants. However, a single peptide (F16: DNEKLRKPKHKKLKQPGDGN) was recognized significantly more frequently by P. falciparum-exposed than nonexposed Thai subjects. T cells responsive to this peptide were CD450+ and produced gamma-interferon. In contrast to the response to the vivax determinants and the other falciparum determinants, responsiveness to F16 was undetectable or minimal 2 years after exposure. Our data provide the average life-spans of certain malaria-specific T cells and are consistent with, but do not prove, the hypothesis that antigenic persistence (in the form of P. vivax hypnozoites) correlates with persistence of human T-cell memory.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517041      PMCID: PMC44149          DOI: 10.1073/pnas.91.13.6118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages.

Authors:  L Rénia; D Grillot; M Marussig; G Corradin; F Miltgen; P H Lambert; D Mazier; G Del Giudice
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

2.  A microplate method of enzyme-linked immunosorbent assay and its application to malaria.

Authors:  A Voller; D Bidwell; G Huldt; E Engvall
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.

Authors:  M Sedegah; B K Sim; C Mason; T Nutman; A Malik; C Roberts; A Johnson; J Ochola; D Koech; B Were
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

4.  In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax.

Authors:  M R Hollingdale; W E Collins; C C Campbell; A L Schwartz
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

5.  Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.

Authors:  S Herrera; P Escobar; C de Plata; G I Avila; G Corradin; M A Herrera
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

6.  'Natural' T cells responsive to malaria: evidence implicating immunological cross-reactivity in the maintenance of TCR alpha beta+ malaria-specific responses from non-exposed donors.

Authors:  J Currier; J Sattabongkot; M F Good
Journal:  Int Immunol       Date:  1992-09       Impact factor: 4.823

7.  Lifespan of human lymphocyte subsets defined by CD45 isoforms.

Authors:  C A Michie; A McLean; C Alcock; P C Beverley
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.

Authors:  W R Weiss; J A Berzofsky; R A Houghten; M Sedegah; M Hollindale; S L Hoffman
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

9.  Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

Authors:  J B Dame; J L Williams; T F McCutchan; J L Weber; R A Wirtz; W T Hockmeyer; W L Maloy; J D Haynes; I Schneider; D Roberts
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

10.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.

Authors:  S Oehen; H Waldner; T M Kündig; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  17 in total

1.  Deletion of Plasmodium berghei-specific CD4+ T cells adoptively transferred into recipient mice after challenge with homologous parasite.

Authors:  C Hirunpetcharat; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

2.  Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.

Authors:  I S Soares; G Levitus; J M Souza; H A Del Portillo; M M Rodrigues
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

Review 3.  Multispecies Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1999-02       Impact factor: 1.276

Review 4.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

5.  Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

6.  Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.

Authors:  Ian A Cockburn; Yun-Chi Chen; Michael G Overstreet; Jason R Lees; Nico van Rooijen; Donna L Farber; Fidel Zavala
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

7.  Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.

Authors:  Jiraprapa Wipasa; Chaisuree Suphavilai; Lucy C Okell; Jackie Cook; Patrick H Corran; Kanitta Thaikla; Witaya Liewsaree; Eleanor M Riley; Julius Clemence R Hafalla
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

8.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

9.  Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.

Authors:  Aissatou Toure-Balde; Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Mouhamadou Ndiaye; Georgette Aribot; Adama Tall; Cheikh Sokhna; Christophe Rogier; Giampietro Corradin; Christian Roussilhon; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

10.  Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy.

Authors:  Y Zevering; C Khamboonruang; M F Good
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.